OncoRay

Recent papers from OncoRay

1. α7 integrin co-regulates chromatin accessibility and gene expression in HPV-negative head and neck cancerSignal Transduction and Targeted Therapy · 2026
2. Outcomes of elderly patients treated with chemoradiotherapy for anal squamous cell carcinoma: a multicenter study of the German cancer consortium - radiation oncology group (DKTK-ROG)Clinical and Translational Radiation Oncology · 2026
3. A versatile phantom-based framework for end-to-end testing of (online) adaptive proton therapy in the head-and-neck regionRadiotherapy and Oncology · 2026
4. External validation of a top-ranked model from the RSNA pulmonary embolism detection challenge: assessment of generalizabilityScientific Reports · 2026
5. Clinical outcomes of linear accelerator-based stereotactic radiosurgery for trigeminal neuralgiaSurgical Neurology International · 2026
6. Ablative radiotherapy in castration‐resistant prostate cancerBJU International · 2026
7. Deep learning-based generation of direct stopping power ratio maps for MR-only proton therapy of primary brain tumor patientsPhysics and Imaging in Radiation Oncology · 2026
8. Feasibility of in-vivo 4D prompt-gamma treatment verification in proton therapy for pancreatic cancerPhysics and Imaging in Radiation Oncology · 2026
9. Significant aggravation of pre-existing myalgic encephalomyelitis/chronic fatigue syndrome following proton beam therapy for sphenoid wing meningioma: case reportStrahlentherapie und Onkologie · 2026
10. Dual‐energy CT for proton therapy: Impact of advanced slice‐wise patient‐thickness estimation methods for improved stopping‐power predictionJournal of Applied Clinical Medical Physics · 2026
11. Deep learning for dose-averaged linear energy transfer estimation in pencil-beam scanning and double scattering proton radiotherapy plans with uncertainty-aware external validationPhysics and Imaging in Radiation Oncology · 2026
12. Six-month evaluation of normal mouse brain side effects: Comparing FLASH and conventional proton partial brain irradiationClinical and Translational Radiation Oncology · 2026
13. De-escalation of adjuvant radio(chemo)therapy for patients with HPV-positive head and neck squamous cell carcinoma: study protocol for a phase I trial to reduce late toxicity (DELPHI).2026
14. Error detection sensitivity and operational efficiency of phantom-based and phantom-less patient-specific quality assurance in proton therapyZeitschrift für Medizinische Physik · 2026
15. Comparison of gantry-less magnetic resonance guided proton therapy with photon therapy for hepatocellular carcinoma patientsPhysics and Imaging in Radiation Oncology · 2026
16. Precise metabolomics identifies glycolysis-related pyruvate kinase M activity as regulator of the S-phase-specific radiation response in triple-negative breast cancer cellsCell Communication and Signaling · 2026
17. Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancerPhysics and Imaging in Radiation Oncology · 2026
18. Study of the over-response of radiochromic films in ultra-high dose rate and dose per pulse electron beamsPhysics in Medicine and Biology · 2026
19. Technical note: Systematic optimization for the rapid generation of high-quality online adapted proton therapy plans in a commercial treatment planning systemRadiotherapy and Oncology · 2026
20. An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapyPhysics and Imaging in Radiation Oncology · 2025